Likewise, the incidence of isolates susceptible to meropenem or colistin showed a decreasing trend from March, while that of resistant isolates reached its peak in April, coinciding with the increase in the use of these antimicrobials.
← all excerpts
Antimicrobial use and aetiology of bloodstream infections in critically ill patients during early stages of SARS-CoV-2 pandemic.
1
—
—